Empowered Funds LLC Takes Position in Cigna Group $CI

Empowered Funds LLC acquired a new position in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 98,708 shares of the health services provider’s stock, valued at approximately $27,212,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. United Capital Financial Advisors LLC acquired a new stake in shares of Cigna Group during the 2nd quarter valued at approximately $3,460,000. Caitlin John LLC acquired a new stake in shares of Cigna Group in the 2nd quarter worth approximately $302,000. Equitable Holdings Inc. purchased a new position in Cigna Group in the 2nd quarter valued at approximately $956,000. Centaurus Financial Inc. acquired a new position in Cigna Group during the second quarter worth $544,000. Finally, FSA Advisors Inc. purchased a new stake in Cigna Group during the second quarter worth $297,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 23,012 shares of company stock worth $6,386,550. Insiders own 0.60% of the company’s stock.

Cigna Group Trading Down 1.3%

Shares of Cigna Group stock opened at $277.21 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The business’s fifty day moving average is $283.53 and its two-hundred day moving average is $281.41. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $73.25 billion, a PE ratio of 11.47, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the business earned $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts anticipate that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio is currently 25.82%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CI shares. UBS Group raised their price target on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Barclays boosted their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Mizuho raised their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Wolfe Research reaffirmed an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.